Injury · 2026
Protocol development for high-resolution transcutaneous CO₂ monitoring in ultra-early detection of free flap compromise.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shibata Ryutaro, Kudo Toshiya, Takeda Shinsuke, Sano Yoshitomo, Nakagawa Shota, Sawaguchi Takeshi, Matsushita Takashi
Аннотация
BACKGROUND: Vascular compromise is a serious complication in free-flap surgery for traumatic reconstruction or fracture-related infections, often leading to partial or total flap loss if not detected promptly. We evaluated transcutaneous partial pressure of carbon dioxide (TcPCO₂) real-time monitoring as an objective, non-invasive method for ultra-early detection of vascular compromise in free flap reconstruction.
METHODS: This sequential cohort study consisted of a retrospective development phase and a prospective validation phase. An abnormality was defined as a rise of >10 mmHg from the baseline TcPCO₂ value, with re-exploration performed if the elevation persisted after recalibration. High-resolution (1-s interval) TcPCO₂ data were analyzed to assess diagnostic accuracy and concordance with arterial partial pressure of carbon dioxide (PaCO₂).
RESULTS: In pilot studies, TcPCO₂ increased within 20-100 s of induced ischemia and correlated strongly with PaCO₂ (r = 0.708, p < 0.001). Among 81 clinical free flap cases (50 retrospective, 31 prospective), TcPCO₂ monitoring detected all seven episodes of vascular compromise with 100% sensitivity and specificity, and no false positives. All the compromised flaps were successfully salvaged. Compared with conventional clinical assessment, TcPCO₂ monitoring provided earlier recognition of perfusion disturbances.
CONCLUSION: TcPCO₂ monitoring is a non-invasive, objective, and reproducible tool for ultra-early detection of vascular compromise in free flap surgery. Its implementation enables timely re-exploration, reduces reliance on subjective bedside assessments, and may significantly improve flap salvage outcomes.
METHODS: This sequential cohort study consisted of a retrospective development phase and a prospective validation phase. An abnormality was defined as a rise of >10 mmHg from the baseline TcPCO₂ value, with re-exploration performed if the elevation persisted after recalibration. High-resolution (1-s interval) TcPCO₂ data were analyzed to assess diagnostic accuracy and concordance with arterial partial pressure of carbon dioxide (PaCO₂).
RESULTS: In pilot studies, TcPCO₂ increased within 20-100 s of induced ischemia and correlated strongly with PaCO₂ (r = 0.708, p < 0.001). Among 81 clinical free flap cases (50 retrospective, 31 prospective), TcPCO₂ monitoring detected all seven episodes of vascular compromise with 100% sensitivity and specificity, and no false positives. All the compromised flaps were successfully salvaged. Compared with conventional clinical assessment, TcPCO₂ monitoring provided earlier recognition of perfusion disturbances.
CONCLUSION: TcPCO₂ monitoring is a non-invasive, objective, and reproducible tool for ultra-early detection of vascular compromise in free flap surgery. Its implementation enables timely re-exploration, reduces reliance on subjective bedside assessments, and may significantly improve flap salvage outcomes.